VH4-34+ hairy cell leukemia, a new variant with poor prognosis despite standard therapy. - Wikidata - wikimedia - TriplyDB

VH4-34+ hairy cell leukemia, a new variant with poor prognosis despite standard therapy.

VH4-34+ hairy cell leukemia, a new variant with poor prognosis despite standard therapy.

http://www.wikidata.org/entity/Q35002178

about

Long-term follow-up after purine analogue therapy in hairy cell leukaemia Class II human leucocyte antigen DRB1*11 in hairy cell leukaemia patients with and without haemolytic uraemic syndrome.Phase 2 study of cladribine followed by rituximab in patients with hairy cell leukemia.The bruton tyrosine kinase inhibitor ibrutinib (PCI-32765) blocks hairy cell leukaemia survival, proliferation and B cell receptor signalling: a new therapeutic approach.Update on the biology and treatment options for hairy cell leukemia.Cladribine with immediate rituximab for the treatment of patients with variant hairy cell leukemia.Recommendations of the SFH (French Society of Haematology) for the diagnosis, treatment and follow-up of hairy cell leukaemia.Evidence of canonical somatic hypermutation in hairy cell leukemia Immunoglobulin transcript sequence and somatic hypermutation computation from unselected RNA-seq reads in chronic lymphocytic leukemia.Both variant and IGHV4-34-expressing hairy cell leukemia lack the BRAF V600E mutation Exome Sequencing in Classic Hairy Cell Leukaemia Reveals Widespread Variation in Acquired Somatic Mutations between Individual Tumours Apart from the Signature BRAF V(600)E Lesion.Impact of telomere length on survival in classic and variant hairy cell leukemia.Immunoconjugates in the management of hairy cell leukemia.Hairy cell leukemia - immunotargets and therapies Molecular subsets of mantle cell lymphoma defined by the IGHV mutational status and SOX11 expression have distinct biologic and clinical features High prevalence of MAP2K1 mutations in variant and IGHV4-34-expressing hairy-cell leukemias.Molecular insight into the biology and clinical course of hairy cell leukemia utilizing immunoglobulin gene analysis.Chemo-immunotherapy for hairy cell leukemia.Insight into the behavior of hairy cell leukemia by immunogenetic analysis.Hairy cell leukaemia: biological and clinical overview from immunogenetic insights.Hairy cell leukemia-new genes, new targets.Novel therapeutic options for relapsed hairy cell leukemia.Hairy cell leukemia: update and current therapeutic approach.Potential breakthroughs with investigational drugs for hairy cell leukemia.Treatment outcomes and secondary cancer incidence in young patients with hairy cell leukaemia.Genetic aberrations in small B-cell lymphomas and leukemias: molecular pathology, clinical relevance and therapeutic targets.NFkB is activated by multiple mechanisms in hairy cell leukemia.How I manage patients with hairy cell leukaemia.Mantle cell lymphoma cell lines show no evident immunoglobulin heavy chain stereotypy but frequent light chain stereotypy.Clinical utility of recently identified diagnostic, prognostic, and predictive molecular biomarkers in mature B-cell neoplasms.CD11c+ T-bet+ memory B cells: Immune maintenance during chronic infection and inflammation?IgG Subclasses and Isotypes of VH4-34 Encoded Antibodies.VH1-44 gene usage defines a subset of canine B-cell lymphomas associated with better patient survival.Long-term durable remission by cladribine followed by rituximab in patients with hairy cell leukaemia: update of a phase II trial.Hairy cell leukemia 2018: Update on diagnosis, risk-stratification, and treatment.Trametinib for the treatment of IGHV4-34, MAP2K1-mutant variant hairy cell leukemia.Peripheral blood 8 colour flow cytometry monitoring of hairy cell leukaemia allows detection of high-risk patients.Genomics of Hairy Cell Leukemia.Hairy cell leukaemia: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.Ibrutinib for relapsed refractory hairy cell leukemia variant.

P2860

Q26776327-7535D9B5-79E9-4279-88C8-6821CEF0D5F2 Q33415933-08BCB68A-4E02-496C-82BC-0EC2F8B6982C Q33844299-F9B5FDD9-F621-4647-B39B-441D98C2DC4E Q33924158-0923BF10-E454-425D-825C-ED54923A9934 Q34343369-A0FB634F-E4BD-487A-B1DF-7E2896979274 Q34387911-E8EAA1C6-5FA6-4002-9466-C4AE67624383 Q34459751-95C4C6F6-7099-4424-B426-DECC8A4D327D Q35001615-6B44513B-006A-41F9-A237-80365307D41E Q35377918-4086A2CF-14CF-419C-940E-667F83E56329 Q35876956-CC974A53-CF81-4AF1-9D4C-92C80D5F16EA Q35922137-03BA9C3C-74AA-437F-9563-88FE3137F644 Q36322450-8A149FC1-A919-4C87-8A58-980EE258159B Q36328016-BB6FA389-DC86-4763-B1B4-613691C9BF08 Q37031666-D5A2A324-0CB2-444A-BB5C-72513B95D0DD Q37149519-95931E45-3052-4DF1-93E8-7A63C296259A Q37528345-DAE068E2-708C-43E9-9F91-04CC59028319 Q37816419-D543EDE4-153C-411E-9D30-D7C6B7AB1E86 Q37854692-8A13AC15-4835-45FA-8239-CD53B67AD15C Q37866773-D1CE7EC3-3EB0-42CB-AB5C-66EE02A08822 Q37889776-64DD1287-EE13-4AB5-A7D1-BE52BF5BA99A Q38124726-101EE1AD-243B-4D4F-B307-C72D8295C849 Q38308974-AD6971A6-ACCE-4300-A6A4-1C474CBBCEA9 Q38518290-E2A49FAF-F296-4A84-9C68-1DCB17C6276B Q38578492-7413630B-0389-485F-81CD-3ACB5F6BD123 Q38805003-FDC7A41D-E7FA-420D-9566-9B319FEDF8B9 Q38819164-04BEC6B8-9FFC-41E6-A171-DE83C285311E Q38876957-EFED6E5D-1855-45A4-ADF4-5110254C40B4 Q39113513-6025AB96-6FAF-4A54-8FFB-CE0F97DB3642 Q39225258-B68BEF40-9FAC-4D79-8397-E6ECC8DCE34D Q39406673-84FBA555-BAB7-4769-B020-B490FFF1B52D Q40071467-003DDA9F-56BA-4A13-BF9D-5CDBF64FBE10 Q41258743-7A00C206-ABDF-4881-919C-D47286087A84 Q41952665-52B90F54-C5E1-4FE2-AC00-7BA35C39E7B5 Q42291047-1530262D-A52B-4AEA-A64D-8AAF73A20EF6 Q47170848-F53ACF13-747E-4721-8B77-3FE1E1A5EF61 Q50054826-FD0D28CE-A175-438B-8201-9D7AA79CF62A Q51746464-6BF909DF-6649-4536-A516-293D8CF8B175 Q52781884-8AAA05B9-BF70-42FD-86A8-CEF6F4D14112 Q53381221-B2E32EC3-543D-435A-B330-43182F9856AE Q54577296-0F1450D5-1ACF-4786-8DF4-6F69B835A17C

P2860

VH4-34+ hairy cell leukemia, a new variant with poor prognosis despite standard therapy.

http://www.wikidata.org/entity/Q35002178

description

2009 nî lūn-bûn

@nan

2009 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած

@hyw

2009 թվականի սեպտեմբերին հրատարակված գիտական հոդված

@hy

2009年の論文

@ja

2009年論文

@yue

2009年論文

@zh-hant

2009年論文

@zh-hk

2009年論文

@zh-mo

2009年論文

@zh-tw

2009年论文

@wuu

name

VH4-34+ hairy cell leukemia, a new variant with poor prognosis despite standard therapy.

@ast

VH4-34+ hairy cell leukemia, a new variant with poor prognosis despite standard therapy.

@en

type

label

VH4-34+ hairy cell leukemia, a new variant with poor prognosis despite standard therapy.

@ast

VH4-34+ hairy cell leukemia, a new variant with poor prognosis despite standard therapy.

@en

prefLabel

VH4-34+ hairy cell leukemia, a new variant with poor prognosis despite standard therapy.

@ast

VH4-34+ hairy cell leukemia, a new variant with poor prognosis despite standard therapy.

@en

P1433

Q35002178-A4B7E6D6-572C-43A1-8A0D-EA906F5C4BDF

P1476

Q35002178-2AFA6490-9683-44A6-A432-A559A59FEF25

P2093

Q35002178-0FF80DA7-7B32-4B42-AE08-0DD7F96FDEB7

Q35002178-871C1C2A-645A-4EBF-86D5-7217392931E1

Q35002178-B6B9697B-74D2-4D2B-A9C7-2466D36C5D80

Q35002178-E9E98F82-C278-4F1C-BCE9-8705A3F5D9D2

P2860

Q35002178-0A8C39BD-9EF0-4F69-9697-A55555C15CDB

Q35002178-0EEC9664-A1D2-48FC-B44D-4CEFBD2D66E4

Q35002178-10D39DFE-0A80-45C7-9C52-74F5BC389C64

Q35002178-1114286B-FE12-4144-A792-1FC997C9B5B1

Q35002178-17638B42-F5F4-4DA0-9012-48E1A89AE81B

Q35002178-1F13B5F9-A282-4B1A-BD4B-102227F10B4A

Q35002178-209AAE9B-FCF3-4B52-A1BC-34453996441E

Q35002178-215DA313-43FB-48F9-BE76-2656183B7F59

Q35002178-2221D029-2D9E-4819-8A0E-3CEE031F4BE5

Q35002178-27477CBA-069D-42E0-ACE3-C7ECB38C50F2

P304

Q35002178-7B77227F-B93F-4201-B65B-D7C35EF77693

P31

Q35002178-6881A6DA-D0FC-4AA5-AA5E-D5637E94C410

P356

Q35002178-F9AC694D-3E45-4AC3-8D7A-A6D5B5E8DCE6

P407

Q35002178-B7169A97-B2D1-41EE-9CFD-C1898A2B439A

P433

Q35002178-972DBF31-5672-4E0D-AE5D-2F003770BFEC

P478

Q35002178-833AC7A8-2403-4609-9A6F-1FDB3B214F73

P577

Q35002178-5B55E213-4527-4CA6-98C4-38035D3D9056

P5875

Q35002178-7B4F0248-A33F-4992-83B4-9393372A6FDD

P698

Q35002178-DBADEE87-3FF1-4E8A-95B8-FF9058536129

P921

Q35002178-87296C80-C1EE-4207-B759-CB4596CCE334

P932

Q35002178-3EC1C626-ED05-437F-9C75-72F025800C74

P356

BLOOD-2009-01-201731

P1433

P1476

VH4-34+ hairy cell leukemia, a new variant with poor prognosis despite standard therapy.

@en

P2093

Evgeny Arons

http://www.w3.org/2001/XMLSchema#string

Maryalice Stetler-Stevenson

http://www.w3.org/2001/XMLSchema#string

Robert J Kreitman

http://www.w3.org/2001/XMLSchema#string

Tara Suntum

http://www.w3.org/2001/XMLSchema#string

P2860

Comparison of immunoglobulin G heavy-chain sequences in MS and SSPE brains reveals an antigen-driven response.

Treatment of hairy cell leukemia-variant with cladribine.

Efficacy of the anti-CD22 recombinant immunotoxin BL22 in chemotherapy-resistant hairy-cell leukemia.

Successful treatment of hairy cell leukemia variant with rituximab.

A variant form of hairy cell leukemia resistant to alpha-interferon: clinical and phenotypic characteristics of 17 patients.

Unmutated Ig V(H) genes are associated with a more aggressive form of chronic lymphocytic leukemia.

The variant form of hairy-cell leukaemia.

A chronic lymphoproliferative disorder with distinctive features: a distinct variant of hairy-cell leukaemia.

Long remissions in hairy cell leukemia with purine analogs: a report of 219 patients with a median follow-up of 12.5 years.

Eradication of minimal residual disease in hairy cell leukemia.

P304

4687-4695

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1182/BLOOD-2009-01-201731

http://www.w3.org/2001/XMLSchema#string

P407

P433

21

http://www.w3.org/2001/XMLSchema#string

P478

114

http://www.w3.org/2001/XMLSchema#string

P577

2009-09-10T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

26803338

http://www.w3.org/2001/XMLSchema#string

P698

19745070

http://www.w3.org/2001/XMLSchema#string

P921

P932

2780305

http://www.w3.org/2001/XMLSchema#string